• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于包裹神经生长因子的新型高密度脂蛋白模拟纳米颗粒的制备与表征

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation.

作者信息

Zhu Jing, Dong Xiaowei

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center.

Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center;

出版信息

J Vis Exp. 2017 May 22(123):55584. doi: 10.3791/55584.

DOI:10.3791/55584
PMID:28570541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5608011/
Abstract

The objective of this article is to introduce preparation and characterization methods for nerve growth factor (NGF)-loaded, high-density, lipoprotein (HDL)-mimicking nanoparticles (NPs). HDLs are endogenous NPs and have been explored as vehicles for the delivery of therapeutic agents. Various methods have been developed to prepare HDL-mimicking NPs. However, they are generally complicated, time consuming, and difficult for industrial scale-up. In this study, one-step homogenization was used to mix the excipients and form the prototype NPs. NGF is a water-soluble protein of 26 kDa. To facilitate the encapsulation of NGF into the lipid environment of HDL-mimicking NPs, protamine USP was used to form an ion-pair complex with NGF to neutralize the charges on the NGF surface. The NGF/protamine complex was then introduced into the prototype NPs. Apolipoprotein A-I was finally coated on the surface of the NPs. NGF HDL-mimicking NPs showed preferable properties in terms of particle size, size distribution, entrapment efficiency, in vitro release, bioactivity, and biodistribution. With the careful design and exploration of homogenization in HDL-mimicking NPs, the procedure was greatly simplified, and the NPs were made scalable. Moreover, various challenges, such as separating unloaded NGF from the NPs, conducting reliable in vitro release studies, and measuring the bioactivity of the NPs, were overcome.

摘要

本文的目的是介绍用于负载神经生长因子(NGF)的高密度脂蛋白(HDL)模拟纳米颗粒(NPs)的制备和表征方法。HDL是内源性纳米颗粒,已被探索用作治疗剂递送的载体。已经开发了各种方法来制备HDL模拟纳米颗粒。然而,它们通常很复杂、耗时且难以进行工业放大生产。在本研究中,采用一步均质化来混合辅料并形成原型纳米颗粒。NGF是一种26 kDa的水溶性蛋白质。为了便于将NGF封装到HDL模拟纳米颗粒的脂质环境中,使用了美国药典鱼精蛋白与NGF形成离子对复合物,以中和NGF表面的电荷。然后将NGF/鱼精蛋白复合物引入原型纳米颗粒中。最后在纳米颗粒表面包被载脂蛋白A-I。NGF HDL模拟纳米颗粒在粒径、粒径分布、包封率、体外释放、生物活性和生物分布方面表现出较好的性能。通过对HDL模拟纳米颗粒中均质化的精心设计和探索,该过程大大简化,并且纳米颗粒可实现规模化生产。此外,还克服了各种挑战,如从纳米颗粒中分离未负载的NGF、进行可靠的体外释放研究以及测量纳米颗粒的生物活性。

相似文献

1
Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation.用于包裹神经生长因子的新型高密度脂蛋白模拟纳米颗粒的制备与表征
J Vis Exp. 2017 May 22(123):55584. doi: 10.3791/55584.
2
Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution.新型模拟高密度脂蛋白的α-生育酚包被纳米颗粒用于包裹神经生长因子的研发及生物分布评估。
Eur J Pharm Biopharm. 2016 Nov;108:126-135. doi: 10.1016/j.ejpb.2016.08.005. Epub 2016 Aug 12.
3
Recombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecin.载脂蛋白 AI 半胱氨酸突变体重组高密度脂蛋白作为 10-羟基喜树碱传递载体。
Cancer Lett. 2010 Dec 1;298(1):26-33. doi: 10.1016/j.canlet.2010.05.023. Epub 2010 Jun 25.
4
Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.重构高密度脂蛋白介导的HZ08和紫杉醇靶向共递送增强了紫杉醇对多药耐药MCF-7乳腺癌细胞的疗效。
Eur J Pharm Sci. 2016 Sep 20;92:11-21. doi: 10.1016/j.ejps.2016.06.017. Epub 2016 Jun 23.
5
Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.脂质包被的聚丙烯酸/磷酸钙纳米颗粒的设计合成作为用于癌症化疗的双pH响应药物递送载体
Chemistry. 2017 May 11;23(27):6586-6595. doi: 10.1002/chem.201700060. Epub 2017 Apr 7.
6
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.用于静脉注射的载多西他赛聚乳酸-羟基乙酸共聚物和聚乳酸-羟基乙酸共聚物-聚乙二醇纳米粒:药代动力学和生物分布特征
Int J Nanomedicine. 2017 Jan 27;12:935-947. doi: 10.2147/IJN.S121881. eCollection 2017.
7
Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.基于席夫碱构建的载多柔比星白蛋白纳米粒的增强肿瘤递药与抗肿瘤效应
Int J Nanomedicine. 2016 Aug 12;11:3875-90. doi: 10.2147/IJN.S108689. eCollection 2016.
8
Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.用于增强细胞摄取和阿霉素按需胞内释放的逐步pH响应性纳米颗粒。
Int J Nanomedicine. 2017 Jun 6;12:4241-4256. doi: 10.2147/IJN.S129748. eCollection 2017.
9
Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.载有光辉霉素的甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒对胰腺癌具有强大的抗肿瘤功效。
Int J Nanomedicine. 2017 Jul 24;12:5255-5269. doi: 10.2147/IJN.S139507. eCollection 2017.
10
Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.用于细胞核靶向抗癌药物递送的新型壳聚糖-鱼精蛋白纳米颗粒的制备与表征
Int J Nanomedicine. 2016 Nov 14;11:6035-6046. doi: 10.2147/IJN.S117066. eCollection 2016.

引用本文的文献

1
A Time-Course Study of the Expression Level of Synaptic Plasticity-Associated Genes in Un-Lesioned Spinal Cord and Brain Areas in a Rat Model of Spinal Cord Injury: A Bioinformatic Approach.一项使用生物信息学方法对脊髓损伤大鼠模型中未受损脊髓和脑区中突触可塑性相关基因表达水平进行时程研究。
Int J Mol Sci. 2021 Aug 10;22(16):8606. doi: 10.3390/ijms22168606.
2
Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?神经生长因子的生物递送:迈向广泛临床应用的限制步骤?
Front Neurosci. 2021 Jul 15;15:695592. doi: 10.3389/fnins.2021.695592. eCollection 2021.
3
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.鼻腔给药的纳米制剂:治疗神经障碍的一种有潜力的方法。
Molecules. 2020 Apr 21;25(8):1929. doi: 10.3390/molecules25081929.
4
Current Strategies for Brain Drug Delivery.当前的脑内药物递送策略。
Theranostics. 2018 Feb 5;8(6):1481-1493. doi: 10.7150/thno.21254. eCollection 2018.

本文引用的文献

1
Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution.新型模拟高密度脂蛋白的α-生育酚包被纳米颗粒用于包裹神经生长因子的研发及生物分布评估。
Eur J Pharm Biopharm. 2016 Nov;108:126-135. doi: 10.1016/j.ejpb.2016.08.005. Epub 2016 Aug 12.
2
A high-density lipoprotein-mediated drug delivery system.高密度脂蛋白介导的药物传递系统。
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):132-147. doi: 10.1016/j.addr.2016.04.030. Epub 2016 May 18.
3
High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.高密度脂蛋白:天然的多功能纳米颗粒。
ACS Nano. 2016 Mar 22;10(3):3015-41. doi: 10.1021/acsnano.5b07522. Epub 2016 Feb 25.
4
HDL as a drug and nucleic acid delivery vehicle.高密度脂蛋白作为一种药物和核酸递送载体。
Front Pharmacol. 2015 Oct 26;6:247. doi: 10.3389/fphar.2015.00247. eCollection 2015.
5
Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.合成高密度脂蛋白样纳米颗粒用于癌症治疗。
Cancer Treat Res. 2015;166:129-50. doi: 10.1007/978-3-319-16555-4_6.
6
Structural stability and functional remodeling of high-density lipoproteins.高密度脂蛋白的结构稳定性与功能重塑
FEBS Lett. 2015 Sep 14;589(19 Pt A):2627-39. doi: 10.1016/j.febslet.2015.02.028. Epub 2015 Mar 5.
7
Long-term delivery of protein therapeutics.蛋白质治疗药物的长期递送。
Expert Opin Drug Deliv. 2015 Mar;12(3):415-40. doi: 10.1517/17425247.2015.961420. Epub 2014 Sep 24.
8
Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.蛋白质和肽类药物递送的最新进展:特别关注聚合物纳米颗粒
Protein Pept Lett. 2014;21(11):1102-20. doi: 10.2174/0929866521666140807114240.
9
High-density lipoproteins for the systemic delivery of short interfering RNA.高密度脂蛋白用于系统递送小干扰 RNA。
Expert Opin Drug Deliv. 2014 Feb;11(2):231-47. doi: 10.1517/17425247.2014.866089. Epub 2013 Dec 9.
10
Basics and recent advances in peptide and protein drug delivery.肽和蛋白质药物递送的基础与最新进展
Ther Deliv. 2013 Nov;4(11):1443-67. doi: 10.4155/tde.13.104.